180 related articles for article (PubMed ID: 23538344)
21. Hepatitis C virus infection can affect lymphoproliferative disorders only as a cofactor for Epstein-Barr virus in liver transplant recipients: PTLD.Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2012 Apr; 10(2):141-7. PubMed ID: 22432758
[TBL] [Abstract][Full Text] [Related]
22. Characteristics and prognosis of lymphoproliferative disorders post-renal transplantation in living versus deceased donor allograft recipients.
Khedmat H; Taheri S
Saudi J Kidney Dis Transpl; 2013 Sep; 24(5):903-9. PubMed ID: 24029253
[TBL] [Abstract][Full Text] [Related]
23. Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
Manlhiot C; Pollock-Barziv SM; Holmes C; Weitzman S; Allen U; Clarizia NA; Ngan BY; McCrindle BW; Dipchand AI
J Heart Lung Transplant; 2010 Jun; 29(6):648-57. PubMed ID: 20304682
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow involvement by lymphoproliferative disorders after renal transplantation: PTLD. Int. Survey.
Izadi M; Fazel M; Saadat SH; Taheri S
J Cancer Res Ther; 2012; 8(1):62-7. PubMed ID: 22531516
[TBL] [Abstract][Full Text] [Related]
25. Very late onset lymphoproliferative disorders occurring over 10 years post-renal transplantation: PTLD.Int. Survey.
Khedmat H; Taheri S
Hematol Oncol Stem Cell Ther; 2011; 4(2):73-80. PubMed ID: 21727768
[TBL] [Abstract][Full Text] [Related]
26. More benign lymphoproliferative disease after liver transplant in infants.
Khedmat H; Ghamar-Chehreh ME; Amini M; Taheri S
Prog Transplant; 2013 Jun; 23(2):158-64. PubMed ID: 23782664
[TBL] [Abstract][Full Text] [Related]
27. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J
Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
[TBL] [Abstract][Full Text] [Related]
28. Colorectal involvement by post-transplant lymphoproliferative disorders: a review of 81 cases.
Khedmat H; Amini M; Ghamar-Chehreh ME
Saudi J Kidney Dis Transpl; 2014 May; 25(3):597-604. PubMed ID: 24821158
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients.
Morton M; Coupes B; Roberts SA; Klapper PE; Byers RJ; Vallely PJ; Ryan K; Picton ML
Transplantation; 2013 Feb; 95(3):470-8. PubMed ID: 23222821
[TBL] [Abstract][Full Text] [Related]
30. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
Muchtar E; Kramer MR; Vidal L; Ram R; Gurion R; Rosenblat Y; Bakal I; Shpilberg O
Transplantation; 2013 Oct; 96(7):657-63. PubMed ID: 23823652
[TBL] [Abstract][Full Text] [Related]
31. Posttransplant Lymphoproliferative Disorder in Kidney and Liver Transplant Recipients: A Single-Center Experience.
Wójciak M; Gozdowska J; Dęborska-Materkowska D; Perkowska-Ptasińska A; Kosieradzki M; Nazarewski S; Durlik M
Transplant Proc; 2018 Sep; 50(7):2154-2158. PubMed ID: 30177129
[TBL] [Abstract][Full Text] [Related]
32. Late onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies.
Khedmat H; Taheri S
Ann Transplant; 2009; 14(4):80-5. PubMed ID: 20009160
[TBL] [Abstract][Full Text] [Related]
33. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.
Leblond V; Sutton L; Dorent R; Davi F; Bitker MO; Gabarre J; Charlotte F; Ghoussoub JJ; Fourcade C; Fischer A
J Clin Oncol; 1995 Apr; 13(4):961-8. PubMed ID: 7707124
[TBL] [Abstract][Full Text] [Related]
34. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371
[TBL] [Abstract][Full Text] [Related]
35. Human leukocyte antigen type and posttransplant lymphoproliferative disorder.
Lustberg ME; Pelletier RP; Porcu P; Martin SI; Quinion CD; Geyer SM; Caligiuri MA; Baiocchi RA
Transplantation; 2015 Jun; 99(6):1220-5. PubMed ID: 25427163
[TBL] [Abstract][Full Text] [Related]
36. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
Kasiske BL; Kukla A; Thomas D; Wood Ives J; Snyder JJ; Qiu Y; Peng Y; Dharnidharka VR; Israni AK
Am J Kidney Dis; 2011 Dec; 58(6):971-80. PubMed ID: 21930332
[TBL] [Abstract][Full Text] [Related]
37. Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era.
Evens AM; Choquet S; Kroll-Desrosiers AR; Jagadeesh D; Smith SM; Morschhauser F; Leblond V; Roy R; Barton B; Gordon LI; Gandhi MK; Dierickx D; Schiff D; Habermann TM; Trappe R
Am J Transplant; 2013 Jun; 13(6):1512-22. PubMed ID: 23721553
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow involvement by lymphoproliferative disorders post liver transplantation: PTLD Int Survey.
Khedmat H; Taheri S
Acta Med Indones; 2012 Jul; 44(3):207-13. PubMed ID: 22983075
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
Rouphael B; Lankireddy S; Lazaryan A; Kukla A; Ibrahim HN; Matas AJ; Issa N
Clin Transplant; 2016 Jan; 30(1):60-5. PubMed ID: 26497471
[TBL] [Abstract][Full Text] [Related]
40. Impact of the posttransplant lymphoproliferative disorder subtype on survival.
Koff JL; Li JX; Zhang X; Switchenko JM; Flowers CR; Waller EK
Cancer; 2018 Jun; 124(11):2327-2336. PubMed ID: 29579330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]